Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ovarian Neoplasms × Watchful Waiting × Clear all

Sponsor

Conditions

Prostatic Neoplasms 4 Squamous Intraepithelial Lesions 2 Papillomavirus Infections 2 Leukemia, Myeloid, Acute 2 HIV Infections 2 Colonic Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Anus Neoplasms 2 Solitary Fibrous Tumor, Pleural 1 Smoldering Multiple Myeloma 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Precancerous Conditions 1 Neurofibrosarcoma 1 Neuroblastoma 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Mesothelioma, Malignant 1 Melanoma 1 Malignant mesenchymal tumor 1 Lung Neoplasms 1 Liposarcoma 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Leiomyosarcoma 1 Kidney Neoplasms 1

Interventions

Paclitaxel 80 Carboplatin 76 Bevacizumab 53 Gemcitabine 29 pembrolizumab 27 liposomal doxorubicin 27 Topotecan 22 olaparib 19 Taxes 17 niraparib 15 Docetaxel 15 Immunoglobulin G 14 Disulfides 14 Cyclophosphamide 14 Cisplatin 11 durvalumab 10 Nivolumab 9 Doxorubicin 8 Albumin-Bound Paclitaxel 8 sargramostim 7 rucaparib 7 fludarabine phosphate 7 fludarabine 7 pazopanib 6 epacadostat 6 avelumab 6 Trabectedin 6 Magnetic Resonance Spectroscopy 6 Ipilimumab 6 Interleukin-2 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡